Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Apple (1)
- Bilski v. Kappos (1)
- Biotechnology (1)
- Copyright infringement (1)
- Copyright law (1)
-
- Diagnostic methods (1)
- Digital Millennium Copyright Act (1)
- Federal Circuit (1)
- File sharing (1)
- Google (1)
- Grokster (1)
- Internet (1)
- Inventions (1)
- Judicial interpretation (1)
- Laboratory Corporation v. Metabolite (1)
- Music industry (1)
- Napster (1)
- Patent law (1)
- Patent system (1)
- Patentability (1)
- Precedents (1)
- Recording industry (1)
- Stare decisis (1)
- Statutory language (1)
- United States Supreme Court (1)
Articles 1 - 2 of 2
Full-Text Articles in Law
Antibiotic Resistance, Jessica D. Litman
Antibiotic Resistance, Jessica D. Litman
Articles
Ten years ago, when I wrote War Stories,' copyright lawyers were fighting over the question whether unlicensed personal, noncommercial copying, performance or display would be deemed copyright infringement. I described three strategies that lawyers for book publishers, record labels, and movie studios had deployed to try to assure that the question was answered the way they wanted it to be. First, copyright owners were labeling all unlicensed uses as "piracy" on the ground that any unlicensed use might undermine copyright owners' control. That epithet helped to obscure the difference between unlicensed uses that invaded defined statutory exclusive rights and other …
Wisdom Of The Ages Or Dead-Hand Control? Patentable Subject Matter For Diagnostic Methods After In Re Bilski, Rebecca S. Eisenberg
Wisdom Of The Ages Or Dead-Hand Control? Patentable Subject Matter For Diagnostic Methods After In Re Bilski, Rebecca S. Eisenberg
Articles
In 1980, the Supreme Court gave a reassuring signal to the then-nascent biotechnology industry about the availability of patent protection for the fruits of its research when it upheld the patentability of a genetically modified living organism in Diamond v. Chakrabarty. Twenty-five years later, the Court seemed poised to reexamine the limits of patentable subject matter for advances in the life sciences when it granted certiorari in Laboratory Corporation v. Metabolite. But the Federal Circuit had not addressed the patentable subject matter issue in Laboratory Corporation, and the Court ultimately dismissed the certiorari p etition as improvidently granted. Five years …